Definition
Metastatic tumour in the vertebral column. Metastatic spinal cord compression (MSCC) is epidural tumour compressing the cord or cauda equina.
Epidemiology
- The spine is the most common site of skeletal metastasis
- Thoracic spine is affected most often, then lumbar and cervical
- Common primaries are breast, prostate, lung, kidney and thyroid
Clinical Features
- Progressive axial pain, worse at night and lying flat. Pain usually precedes neurological loss
- Movement related pain suggests mechanical instability
- Radicular pain, limb weakness, sensory level and sphincter disturbance in MSCC
Investigations
- Urgent MRI of the whole spine with contrast
- CT for bone quality and instability
- Staging CT and biopsy when the primary is unknown
Classification
The Spine Instability Neoplastic Score (SINS) combines location, pain, bone lesion quality, alignment, vertebral body collapse and posterolateral involvement.
SINS total score
| Score | Interpretation |
|---|---|
| 0 to 6 | Stable |
| 7 to 12 | Indeterminate |
| 13 to 18 | Unstable |
Bilsky epidural spinal cord compression scale, grades 0 to 3
| Grade | Cord |
|---|---|
| 0 and 1 | Cord not compressed |
| 2 and 3 | Cord compressed |
Management
- Dexamethasone. Start when cord compression is suspected
- External beam radiotherapy. Effective for radiosensitive tumours such as lymphoma, myeloma and seminoma
- Stereotactic radiosurgery. Used for radioresistant tumours such as renal cell carcinoma, melanoma and sarcoma
- Surgery. Separation surgery with posterior stabilisation for high grade compression or instability
- In 101 patients with MSCC, surgery followed by radiotherapy let 84% walk after treatment against 57% with radiotherapy alone
- NOMS framework weighs neurological status, oncological sensitivity, mechanical stability and systemic disease
References
Patchell RA, Tibbs PA, Regine WF, Payne R, Saris S, Kryscio RJ, Mohiuddin M, Young B. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet. 2005, 366(9486), 643-8. PubMed
Fisher CG, DiPaola CP, Ryken TC, Bilsky MH, Shaffrey CI, Berven SH, Harrop JS, Fehlings MG, Boriani S, Chou D, Schmidt MH, Polly DW, Biagini R, Burch S, Dekutoski MB, Ganju A, Gerszten PC, Gokaslan ZL, Groff MW, Liebsch NJ, Mendel E, Okuno SH, Patel S, Rhines LD, Rose PS, Sciubba DM, Sundaresan N, Tomita K, Varga PP, Vialle LR, Vrionis FD, Yamada Y, Fourney DR. A novel classification system for spinal instability in neoplastic disease: an evidence-based approach and expert consensus from the Spine Oncology Study Group. Spine (Phila Pa 1976). 2010, 35(22), E1221-9. PubMed
Laufer I, Rubin DG, Lis E, Cox BW, Stubblefield MD, Yamada Y, Bilsky MH. The NOMS framework: approach to the treatment of spinal metastatic tumors. Oncologist. 2013, 18(6), 744-51. PubMed
Reviewed by Professor Phong Tran, Head of Orthopaedic Surgery, Western Health. Last updated 21 October 2026.